NO20000513L - Oligonukleotidreverstranskripsjonsprimere for effektiv detektering av HIV-1 og HIV-2 og metoder for anvendelse derav - Google Patents

Oligonukleotidreverstranskripsjonsprimere for effektiv detektering av HIV-1 og HIV-2 og metoder for anvendelse derav

Info

Publication number
NO20000513L
NO20000513L NO20000513A NO20000513A NO20000513L NO 20000513 L NO20000513 L NO 20000513L NO 20000513 A NO20000513 A NO 20000513A NO 20000513 A NO20000513 A NO 20000513A NO 20000513 L NO20000513 L NO 20000513L
Authority
NO
Norway
Prior art keywords
hiv
methods
effective detection
transcription primers
oligonucleotide transcription
Prior art date
Application number
NO20000513A
Other languages
English (en)
Other versions
NO327727B1 (no
NO20000513D0 (no
Inventor
David R Patterson
John A Puskas
Keming Song
Jeffrey M Linnen
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of NO20000513D0 publication Critical patent/NO20000513D0/no
Publication of NO20000513L publication Critical patent/NO20000513L/no
Publication of NO327727B1 publication Critical patent/NO327727B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
NO20000513A 1999-02-02 2000-02-01 Fremgangsmate for revers transkribering og deteksjon av HIV-RNA i en biologisk prove, oligonukleotid og kit. NO327727B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11841799P 1999-02-02 1999-02-02

Publications (3)

Publication Number Publication Date
NO20000513D0 NO20000513D0 (no) 2000-02-01
NO20000513L true NO20000513L (no) 2000-08-03
NO327727B1 NO327727B1 (no) 2009-09-14

Family

ID=22378462

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000513A NO327727B1 (no) 1999-02-02 2000-02-01 Fremgangsmate for revers transkribering og deteksjon av HIV-RNA i en biologisk prove, oligonukleotid og kit.

Country Status (13)

Country Link
US (1) US6303293B1 (no)
EP (1) EP1026263B1 (no)
JP (1) JP2000342274A (no)
KR (1) KR100901084B1 (no)
CN (1) CN1186455C (no)
AT (1) ATE397099T1 (no)
AU (1) AU761066B2 (no)
CA (1) CA2295920C (no)
DE (1) DE60038993D1 (no)
DK (1) DK1026263T3 (no)
ES (1) ES2306648T3 (no)
NO (1) NO327727B1 (no)
PT (1) PT1026263E (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8036741B2 (en) 1996-04-30 2011-10-11 Medtronic, Inc. Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure
US6449507B1 (en) 1996-04-30 2002-09-10 Medtronic, Inc. Method and system for nerve stimulation prior to and during a medical procedure
US7269457B2 (en) 1996-04-30 2007-09-11 Medtronic, Inc. Method and system for vagal nerve stimulation with multi-site cardiac pacing
US7225019B2 (en) 1996-04-30 2007-05-29 Medtronic, Inc. Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure
US6479523B1 (en) * 1997-08-26 2002-11-12 Emory University Pharmacologic drug combination in vagal-induced asystole
CA2376903A1 (en) 1999-06-25 2001-01-04 Emory University Devices and methods for vagus nerve stimulation
JP4824236B2 (ja) * 1999-07-09 2011-11-30 ジェン−プローブ・インコーポレーテッド 核酸増幅によるｈｉｖ−１の検出
CA2318730C (en) * 1999-09-20 2008-01-22 Ortho-Clinical Diagnostics, Inc. A method for reverse transcribing rna isolated in dry form
US6487446B1 (en) 2000-09-26 2002-11-26 Medtronic, Inc. Method and system for spinal cord stimulation prior to and during a medical procedure
EP1399585B1 (en) 2000-10-23 2008-02-20 Gen-Probe Incorporated Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
EP2251442B9 (en) * 2003-12-19 2012-04-25 Gen-Probe Incorporated Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2
CN100340673C (zh) * 2005-02-03 2007-10-03 上海科华生物工程股份有限公司 人类免疫缺陷病毒hiv－1核酸扩增－荧光定量检测试剂盒
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
US8620425B2 (en) 2010-04-29 2013-12-31 Medtronic, Inc. Nerve signal differentiation in cardiac therapy
US8639327B2 (en) 2010-04-29 2014-01-28 Medtronic, Inc. Nerve signal differentiation in cardiac therapy
US8406868B2 (en) 2010-04-29 2013-03-26 Medtronic, Inc. Therapy using perturbation and effect of physiological systems
US8706223B2 (en) 2011-01-19 2014-04-22 Medtronic, Inc. Preventative vagal stimulation
US8781582B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8718763B2 (en) 2011-01-19 2014-05-06 Medtronic, Inc. Vagal stimulation
US8725259B2 (en) 2011-01-19 2014-05-13 Medtronic, Inc. Vagal stimulation
US8781583B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
WO2013111800A1 (ja) 2012-01-25 2013-08-01 独立行政法人科学技術振興機構 Ｈｉｖ検出用オリゴヌクレオチド、ｈｉｖ検出キット、及びｈｉｖ検出方法
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10385410B2 (en) 2014-05-27 2019-08-20 Universite Paris Descartes In vitro method for the detection and quantification of HIV-2
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
MA45783A (fr) * 2016-07-29 2019-06-05 Juno Therapeutics Inc Procédés d'évaluation de la présence ou de l'absence d'un virus compétent pour la réplication
WO2018045425A1 (en) * 2016-09-07 2018-03-15 St Vincent's Hospital Sydney Limited Methods of detecting lentivirus
CN106498095A (zh) * 2016-11-14 2017-03-15 湖南圣湘生物科技有限公司 一种人类免疫性缺陷病毒2型核酸检测试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE423856T1 (de) 1989-06-02 2009-03-15 Pasteur Institut Nukleotid-sequenzen von hiv-1, hiv-2 und siv retrovirusgenomen, ihre verwendung zur amplifizierung von pol-sequenzen dieser retroviren und zur in vitro diagnostik von diesen viren verursachten infektionen
US5478724A (en) 1991-08-16 1995-12-26 The Rockefeller University Lentivirus-specific nucleotide probes and methods of use
ATE174382T1 (de) 1992-10-06 1998-12-15 Dade Behring Marburg Gmbh Retrovirus aus der hiv-gruppe und dessen verwendung
US5599662A (en) * 1995-02-17 1997-02-04 Hoffmann-La Roche Inc. Oliconucleotide primers and probes for the detection of HIV-1
US5962665A (en) 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2

Also Published As

Publication number Publication date
PT1026263E (pt) 2008-08-27
DK1026263T3 (da) 2008-09-08
ES2306648T3 (es) 2008-11-16
KR100901084B1 (ko) 2009-06-08
KR20010014470A (ko) 2001-02-26
AU761066B2 (en) 2003-05-29
EP1026263A2 (en) 2000-08-09
US6303293B1 (en) 2001-10-16
NO327727B1 (no) 2009-09-14
AU1482900A (en) 2000-08-03
CN1271020A (zh) 2000-10-25
ATE397099T1 (de) 2008-06-15
DE60038993D1 (de) 2008-07-10
EP1026263B1 (en) 2008-05-28
CN1186455C (zh) 2005-01-26
EP1026263A3 (en) 2000-10-11
CA2295920A1 (en) 2000-08-02
JP2000342274A (ja) 2000-12-12
CA2295920C (en) 2013-10-29
NO20000513D0 (no) 2000-02-01

Similar Documents

Publication Publication Date Title
NO20000513L (no) Oligonukleotidreverstranskripsjonsprimere for effektiv detektering av HIV-1 og HIV-2 og metoder for anvendelse derav
DK0887427T3 (da) Amplifikation og detektion af HIV-1 og/eller HIV-2
NO20000536L (no) Oligonucleotide primere for effektiv detektering av Hepatitt C-virus (HCV) og metoder for anvendelse derav
FR16C0028I2 (fr) Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques
DE60023300D1 (de) Verwendung von cpg als adjuvans für hivimpstoff
TR199701669A1 (xx) Deri preparasyonu i�in bile�imler.
DE60041489D1 (de) Nachweis von hiv-1 durch amplifizierung von nukleinsäuren
DE60132924D1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
NO20000514D0 (no) Oligonukleotidprimere for effektiv multipleks deteksjon av Hepatitis C-virus (HCV) og human immunmangelvirus (HIV) og metoder for anvendelse derav
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
WO2002022076A3 (en) Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
EP1407042A4 (en) DEVICE AND METHODS FOR MONITORING ANTIRETROVIRAL THERAPY INHIBITING PROTEASE AND DETERMINING THERAPEUTIC DECISIONS IN THE TREATMENT OF HIV / AIDS
WO2001027330A3 (en) Screening for disease susceptibility by genotyping the ccr5 and ccr2 genes
DE60229624D1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion
WO2002022781A3 (en) Non-nucleoside reverse transcriptase inhibitor as antiretroviral therapy
이두식 et al. Detection of human immunodeficiency virus (HIV) type 1 provial sequences of peripheral blood mononuclear cells by using polymerase chain reaction
DE69426574D1 (de) Makrocyclische difluorostatonderivate als antivirale mittel
CY1108543T1 (el) Εμβολια dna που κωδικοποιουν βοηθητικες πρωτεϊνες του hiv

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees